Hepatic mitochondrion

Hepatic mitochondria are double-membrane-bound organelles within hepatocytes that serve as the primary site for energy production via oxidative phosphorylation and the citric acid cycle (StatPearls). They are uniquely involved in critical metabolic processes including the urea cycle, heme biosynthesis, and the beta-oxidation of fatty acids, making them central to systemic metabolic homeostasis (NIH). Mitochondrial dysfunction in the liver is a key driver of pathologies such as metabolic dysfunction-associated steatotic liver disease (MASLD), where impaired electron transport and increased reactive oxygen species (ROS) production lead to inflammation and fibrosis (PubMed). Furthermore, hepatic mitochondria are frequent targets of drug-induced liver injury (DILI), where compounds or their metabolites interfere with mitochondrial respiration or induce the opening of the mitochondrial permeability transition pore (mPTP), leading to cell death (Journal of Hepatology). Therapeutic strategies often focus on protecting mitochondrial integrity or enhancing their metabolic efficiency to treat chronic liver conditions (PubMed). Specific molecular components within these organelles, such as the electron transport chain complexes, are often the actual binding sites for drugs like metformin (NIH).

Other names

Liver mitochondrionHepatic mitochondria

Modulation of the electron transport chain, uncoupling of oxidative phosphorylation, and regulation of the mitochondrial permeability transition pore (mPTP).